查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1818190

CT-NG 檢測市場報告：2031 年趨勢、預測與競爭分析

CT-NG Testing Market Report: Trends, Forecast and Competitive Analysis to 2031
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球CT-NG檢測市場前景光明，診斷實驗室和醫院診所都蘊藏著巨大的機會。預計2025年至2031年，全球CT-NG檢測市場的複合年成長率將達到8.2%。該市場的主要驅動力在於市場擴張和診斷工具技術活性化的投資和資金籌措的增加。

  • 根據 Lucintel 的預測，由於實驗室測試具有更高的敏感性和特異性，預計在預測期內各類實驗室測試將出現更高的成長。
  • 從應用角度來看，由於 PoC 和自我測試技術的日益普及，診斷實驗室預計將實現高速成長。
  • 按地區分類，預計北美將在預測期內實現最高成長。

CT-NG檢測市場新趨勢

受技術進步、意識提升和醫療保健重點變化等新興趨勢的影響，CT-NG 檢測市場正在不斷發展。這些趨勢正在改變 CT-NG 檢測的執行方式，使其更快、更準確，並惠及更廣泛的人群。以下是塑造 CT-NG 檢測市場未來的五個關鍵趨勢。

  • 就地檢驗(POCT) 的普及率不斷提升：就地檢驗(CT-NG) 檢測市場的一大趨勢。 POCT 能夠提供快速且準確的結果，不僅方便快捷，還具備在傳統醫療機構之外進行個人檢測的潛力。這一趨勢將對農村和服務欠缺地區產生特別顯著的影響，因為這些地區缺乏實驗室檢測。即時檢測可以縮短週轉時間，提高檢測頻率，並提高早期發現和治療的可能性。
  • 家用檢測套組的成長：受消費者對隱私、便利和健康控制的需求推動，家用檢測套組在性傳染感染（CT-NG）檢測市場迅速普及。這些套件允許個人採集檢體並將其送至實驗室進行分析，這使得性傳染感染檢測更加便捷，尤其是在醫療機構資源有限的社區。隨著診斷技術的進步，家用檢測預計將得到推廣，為診所檢測提供可靠且經濟高效的替代方案。
  • 更精準的分子診斷：分子診斷，尤其是核酸增幅檢查(NAAT)，正成為衣原體感染 (CT-NG) 檢測的黃金標準。這些檢測具有高靈敏度和特異性，是準確檢測披衣菌感染衣原體和淋病奈瑟菌的理想選擇。分子診斷因其準確性高、能夠檢測低細菌載量以及兼容多種檢體類型（包括尿液和自採樣檢體）而在全球範圍內日益普及。
  • 與數位健康平台的整合：性傳染感染陰性（CT-NG）檢測與數位健康平台的整合是另一個日益成長的趨勢。行動應用程式和線上平台使個人能夠預約性傳播感染檢測、獲取檢測結果並接受遠端醫療諮詢。這種數位化轉變預計將提高檢測頻率，並透過為個人提供更方便的檢測和護理途徑來改善公共衛生結果。這一趨勢對於青少年和年輕人等高危險群尤其重要。
  • 預防性醫療保健日益受到重視：預防性醫療保健在新生兒破傷風 (CT-NG) 檢測市場中發展勢頭強勁。各國政府和醫療保健機構正將性傳染感染 (STI)篩檢作為常規體檢的一部分，尤其重視性活躍族群。定期篩檢以及安全性行為教育被視為降低性傳染感染發生率和促進早期診斷的關鍵策略。這種預防性方法正在重塑市場，導致對價格合理且易於獲取的新生兒破傷風 (CT-NG) 檢測解決方案的需求日益成長。

就地檢驗、家用套件以及分子診斷興起等趨勢的推動，性傳染感染（CT-NG）檢測市場正經歷重大變革時期。這些發展正在重塑性傳染感染（STI）檢測的執行方式，使其更易於取得、更準確、更便捷，惠及更廣泛的人群。

CT-NG檢測市場的最新趨勢

近期，在診斷創新、認知度提升以及對便利檢測解決方案需求不斷成長的推動下，性傳染感染 (CT-NG) 檢測市場呈現出顯著趨勢。以下是塑造性傳染感染 (CT-NG) 檢測市場的五大關鍵發展，反映了性傳染感染 (STI) 檢測在準確性、速度和患者可近性方面的進步。

  • FDA核准快速檢測套組：披衣菌感染（CT-NG）檢測市場的最新進展是 FDA核准了披衣菌感染和淋病快速診斷套件。這些套件只需傳統實驗室檢測所需時間的一小部分即可獲得結果，為患者和醫療保健提供者提供了便捷的解決方案。這項創新有望顯著改善性傳染感染（STI）的篩檢和治療，尤其是在急診、診所和社區健康機構。
  • 分子診斷的擴展：核酸增幅檢查(NAAT) 等分子診斷方法的廣泛應用提高了性傳播感染 (CT-NG) 檢測的敏感度和特異性。這些檢測可以檢測到較低的細菌量，即使在無症狀個體中也能提供更準確的結果。許多醫療保健系統，包括美國、德國和日本的醫療保健系統，由於其可靠性，正逐漸將分子檢測作為性傳染感染 (STI)篩檢的標準方法。
  • 自測檢測套組的開發：CT-NG 的自測檢測套組已成為市場變革者，讓個人能夠在自己家中私密地檢測性傳染感染。這些套件允許使用者在家中採集樣本並將其送至實驗室進行分析。這項創新增加了人們獲得檢測的機會，尤其是在傳統醫療基礎設施有限的地區。自測檢測套組的便利性和隱私性推動了其廣泛應用。
  • 與遠端醫療的日益融合：遠端醫療已成為性傳播感染（CT-NG）檢測的重要推動力，使患者能夠遠距接受性傳播感染（STI）檢測和諮詢服務。將檢測與遠端醫療服務結合的數位醫療平台正變得越來越普遍，為使用者提供虛擬諮詢、檢測預約和結果解讀服務。這一發展尤其有利於服務於服務匱乏的人群，改善醫療保健的可近性，並提升患者的便利性。
  • 政府支持的性傳染感染檢測宣傳活動：世界各國政府正在加強推廣性傳染感染檢測，尤其是在年輕人和高危險群中。美國、印度和中國等國的公共衛生措施提高了人們對定期檢測和早期發現重要性的認知。政府對性傳染感染篩檢計畫和教育宣傳活動的資助，促進了CT-NG檢測的廣泛應用。

這些發展凸顯了CT-NG檢測市場的持續演變，其特點是檢測技術的創新、可近性的提高以及公眾健康意識的提升。隨著這些進步持續塑造市場，CT-NG檢測的未來將更加光明，更具包容性。

目錄

第1章執行摘要

第2章 市場概況

  • 背景和分類
  • 供應鏈

第3章：市場趨勢及預測分析

  • 宏觀經濟趨勢與預測
  • 產業驅動力與挑戰
  • PESTLE分析
  • 專利分析
  • 法規環境

4.按類型分類的全球 CT-NG 檢測市場

  • 概述
  • 按類型進行吸引力分析
  • 實驗室檢驗：趨勢與預測（2019-2031）
  • PoC 測試：趨勢與預測（2019-2031）
  • 其他：趨勢與預測（2019-2031）

第5章全球 CT-NG 測試市場（按應用）

  • 概述
  • 按用途進行吸引力分析
  • 診斷實驗室：趨勢與預測（2019-2031）
  • 醫院與診所：趨勢與預測（2019-2031）
  • 其他：趨勢與預測（2019-2031）

第6章 區域分析

  • 概述
  • 區域 CT-NG 測試市場

7.北美CT-NG檢測市場

  • 概述
  • 美國CT-NG檢測市場
  • 墨西哥的CT-NG檢測市場
  • 加拿大 CT-NG 檢測市場

八、歐洲CT-NG檢測市場

  • 概述
  • 德國CT-NG檢測市場
  • 法國CT-NG檢測市場
  • 西班牙CT-NG檢測市場
  • 義大利CT-NG檢測市場
  • 英國CT-NG 檢測市場

9.亞太CT-NG檢測市場

  • 概述
  • 日本CT-NG檢測市場
  • 印度CT-NG檢測市場
  • 中國CT-NG檢測市場
  • 韓國CT-NG檢查市場
  • 印尼CT-NG檢測市場

第10章世界其他地區 CT-NG 測試市場

  • 概述
  • 中東CT-NG檢測市場
  • 南美洲CT-NG檢查市場
  • 非洲CT-NG檢測市場

第11章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析
    • 競爭對手之間的競爭
    • 買方的議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 新進入者的威脅
  • 市佔率分析

第12章：機會與策略分析

  • 價值鏈分析
  • 成長機會分析
    • 按類型分類的成長機會
    • 按應用分類的成長機會
  • 全球 CT-NG 檢測市場的新趨勢
  • 戰略分析
    • 新產品開發
    • 認證和許可
    • 合併、收購、協議、合作和合資企業

第13章 價值鏈主要企業的公司簡介

  • 競爭分析
  • Roche
  • Hologic
  • Thermo Fisher Scientific
  • Abbott Laboratories
  • Bio-Rad Laboratories
  • Siemens Healthineers
  • Danaher

第14章 附錄

  • 圖表目錄
  • 表格一覽
  • 調查方法
  • 免責聲明
  • 版權
  • 簡稱和技術單位
  • 關於我們
  • 聯絡處

The future of the global CT-NG testing market looks promising with opportunities in the diagnostic laboratories and hospitals & clinics markets. The global CT-NG testing market is expected to grow with a CAGR of 8.2% from 2025 to 2031. The major drivers for this market are the boosting investments & funding to fuel market expansion. and the technological advancements in diagnostic tools.

  • Lucintel forecasts that, within the type category, lab tests is expected to witness higher growth over the forecast period due to lab tests are equipped with higher sensitivity and specificity.
  • Within the application category, diagnostic laboratories is expected to witness the higher growth due to growing adoption of PoC and self-testing technologies.
  • In terms of region, North America is expected to witness the highest growth over the forecast period.

Emerging Trends in the CT-NG Testing Market

The CT-NG testing market is evolving with emerging trends driven by technological advancements, increasing awareness, and shifting healthcare priorities. These trends are transforming the way CT-NG testing is conducted, making it faster, more accurate, and accessible to a broader population. Below are five key trends shaping the future of the CT-NG testing market.

  • Increased Adoption of Point-of-Care Testing (POCT): Point-of-care testing is becoming a significant trend in the CT-NG testing market. With rapid and accurate results, POCT offers convenience and the potential to test individuals outside of traditional healthcare settings. This trend is particularly impactful in rural or underserved areas, where access to lab-based testing is limited. The ability to test on-site reduces turnaround times, increases testing frequency, and improves the likelihood of early detection and treatment.
  • Growth of At-Home Testing Kits: At-home testing kits are rapidly gaining popularity in the CT-NG testing market, driven by consumer demand for privacy, convenience, and control over their health. These kits, which allow individuals to collect samples and send them to labs for analysis, make STI testing more accessible, especially in communities with limited access to healthcare facilities. As diagnostic technologies improve, at-home testing is expected to expand, offering a reliable and cost-effective alternative to in-clinic testing.
  • Molecular Diagnostics for Higher Accuracy: Molecular diagnostics, particularly NAAT (Nucleic Acid Amplification Test), are becoming the gold standard for CT-NG testing. These tests offer high sensitivity and specificity, making them ideal for accurate detection of Chlamydia trachomatis and Neisseria gonorrhoeae. Molecular diagnostics are being increasingly adopted globally due to their accuracy, ability to detect low bacterial loads, and suitability for a range of sample types, such as urine or self-collected samples.
  • Integration with Digital Health Platforms: The integration of CT-NG testing with digital health platforms is another growing trend. Mobile apps and online platforms are enabling individuals to manage their STI testing schedules, access results, and receive telehealth consultations. This digital shift is expected to drive more frequent testing and improve public health outcomes by providing individuals with easier access to testing and care. The trend is particularly relevant in high-risk populations, such as adolescents and young adults.
  • Increased Focus on Preventative Healthcare: Preventative healthcare is gaining momentum in the CT-NG testing market. Governments and healthcare providers are placing more emphasis on STI screening as part of routine health checkups, particularly for sexually active individuals. Regular screening, along with education on safe sexual practices, is seen as a key strategy for reducing the incidence of STIs and promoting early diagnosis. This preventative approach is reshaping the market, leading to increased demand for affordable and accessible CT-NG testing solutions.

The CT-NG testing market is undergoing significant transformations, driven by trends such as the rise of point-of-care testing, at-home kits, and molecular diagnostics. These developments are reshaping how STI testing is conducted, improving accessibility, accuracy, and convenience for a broader population.

Recent Developments in the CT-NG Testing Market

The CT-NG testing market has experienced significant developments in recent years, driven by innovations in diagnostic technologies, increased awareness, and growing demand for accessible testing solutions. Below are five key developments shaping the CT-NG testing landscape, which reflect advancements in accuracy, speed, and patient access to STI testing.

  • FDA Approval of Rapid Testing Kits: Recent developments in the CT-NG testing market have seen the FDA's approval of rapid diagnostic kits for Chlamydia and Gonorrhea. These kits provide results in a fraction of the time required for traditional laboratory tests, offering a convenient solution for both patients and healthcare providers. This innovation has the potential to significantly improve STI screening and treatment, particularly in emergency departments, clinics, and community health settings.
  • Expansion of Molecular Diagnostics: The widespread adoption of molecular diagnostics, such as NAAT (Nucleic Acid Amplification Tests), has improved the sensitivity and specificity of CT-NG testing. These tests can detect lower bacterial loads and offer more accurate results, even in asymptomatic individuals. Many healthcare systems, including those in the U.S., Germany, and Japan, are transitioning to molecular testing as the standard method for STI screening due to its reliability.
  • Development of Self-Testing Kits: Self-testing kits for CT-NG have emerged as a game-changer in the market, providing individuals with the ability to test for STIs in the privacy of their own homes. These kits allow users to collect samples at home, which are then sent to a lab for analysis. This innovation has increased access to testing, especially in areas where traditional healthcare infrastructure is limited. The convenience and privacy of self-testing kits are driving their adoption.
  • Increased Integration with Telemedicine: Telemedicine has become a key enabler of CT-NG testing, allowing patients to access STI testing and counseling services remotely. Digital health platforms that integrate testing with telemedicine services are becoming more widespread, providing users with virtual consultations, test ordering, and result interpretation. This development is particularly beneficial in reaching underserved populations, improving access to healthcare, and enhancing patient convenience.
  • Government-Backed STI Testing Campaigns: Governments worldwide have increased their efforts to promote STI testing, with a particular focus on young adults and high-risk populations. Public health initiatives in countries like the U.S., India, and China have led to greater awareness of the importance of regular testing and early detection. Government funding for STI screening programs, as well as educational campaigns, are contributing to the widespread adoption of CT-NG testing.

These developments highlight the ongoing progress in the CT-NG testing market, characterized by innovations in testing technologies, increased accessibility, and a greater focus on public health awareness. As these advancements continue to shape the market, the future of CT-NG testing looks brighter and more inclusive.

Strategic Growth Opportunities in the CT-NG Testing Market

The CT-NG testing market offers various growth opportunities across key applications, particularly in healthcare diagnostics, public health programs, and point-of-care settings. As demand for STI testing rises globally, companies can leverage new technologies and expanding market access to capture growth. Below are five strategic growth opportunities for CT-NG testing in different applications?

  • Point-of-Care Testing in Rural Areas: Expanding point-of-care testing solutions in rural and underserved areas represents a significant growth opportunity. By providing quick and accurate results outside traditional lab settings, these solutions can increase accessibility for populations with limited healthcare access. This would improve STI detection and treatment, particularly in remote regions of developing countries.
  • Adoption of At-Home Self-Testing Kits: The increasing popularity of at-home self-testing kits offers a lucrative growth opportunity in the CT-NG testing market. With privacy and convenience being significant concerns, these kits allow users to collect samples in their own homes and send them to labs for analysis. As the demand for at-home diagnostics rises, the market for these self-testing kits is expected to expand.
  • Integration with Telehealth and Digital Platforms: Telehealth has become a growing trend in healthcare, and integrating CT-NG testing with telemedicine platforms can create growth opportunities. This model offers virtual consultations, remote testing orders, and accessible results, making STI testing more convenient. The integration of digital health tools is expected to drive testing adoption rates and make healthcare services more accessible to global populations.
  • Government-Funded Public Health Initiatives: Governments worldwide are investing in STI testing and prevention programs. Public health campaigns, particularly in countries like the U.S., China, and India, represent a growth opportunity for CT-NG testing providers. By partnering with governments, companies can expand testing accessibility and raise awareness of the importance of early detection.
  • Expansion into Emerging Markets: Emerging markets, particularly in Africa and Asia, present significant growth opportunities for CT-NG testing. Rising awareness of STIs, combined with the adoption of cost-effective, mobile-based diagnostics, creates a vast market for CT-NG testing. Companies entering these markets can play a key role in improving sexual health awareness and offering essential testing services to underserved populations.

The CT-NG testing market offers several strategic growth opportunities, including expanding access through point-of-care and self-testing kits, leveraging telehealth platforms, and tapping into emerging markets. These opportunities will be crucial in driving the growth of the market and improving global STI testing rates.

CT-NG Testing Market Driver and Challenges

The CT-NG testing market is influenced by a mix of technological, economic, and regulatory drivers and challenges. Key drivers, such as advances in diagnostics and increasing public health initiatives, foster market growth, while challenges like cost and regulatory hurdles pose obstacles to wider adoption. Below are the primary drivers and challenges impacting the market.

The factors responsible for driving the CT-NG testing market include:

1. Advancements in Diagnostic Technology: The development of more accurate and faster diagnostic tools, such as NAAT, is a key driver in the CT-NG testing market. These technologies offer higher sensitivity and specificity, making it easier to detect infections and improve treatment outcomes.

2. Growing Public Health Awareness: Rising awareness of sexually transmitted infections and the importance of early detection is increasing the demand for CT-NG testing. Public health campaigns and educational programs are encouraging more people to get tested regularly.

3. Rising Demand for Convenient Testing Options: Consumers are increasingly seeking more convenient testing options, such as point-of-care testing and at-home self-testing kits. These options provide faster results and greater accessibility, driving demand for innovative diagnostic solutions.

4. Government Support for STI Prevention: Governments across the world are promoting STI testing as part of national public health strategies. Funding for STI prevention programs, as well as subsidies for diagnostic tests, is expanding access to testing and driving market growth.

5. Growing Incidence of STIs: The increasing incidence of Chlamydia and Gonorrhea infections globally is driving the demand for CT-NG testing. As more individuals are diagnosed with STIs, the need for regular and accessible testing becomes even more pressing.

Challenges in the CT-NG testing market are:

1. High Cost of Testing: The cost of advanced diagnostic tests remains a significant challenge, particularly in low-income regions. The high price of testing equipment and reagents can limit access to CT-NG testing, particularly in developing countries.

2. Limited Access in Rural Areas: Despite advances in testing technologies, access to CT-NG testing remains limited in rural and remote areas, where healthcare infrastructure is underdeveloped. This disparity in access hinders the widespread adoption of testing.

3. Regulatory Barriers: Stringent regulatory standards for testing products can delay market entry for new diagnostic technologies. Regulatory approval processes vary by region, which can create barriers for companies trying to expand into new markets.

The CT-NG testing market is driven by advancements in diagnostic technologies, rising awareness, and government initiatives, but faces challenges related to cost, access, and regulation. These factors collectively shape the market's growth and will continue to influence its development in the coming years.

List of CT-NG Testing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies CT-NG testing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the CT-NG testing companies profiled in this report include-

  • Roche
  • Hologic
  • Thermo Fisher Scientific
  • Abbott Laboratories
  • Bio-Rad Laboratories
  • Siemens Healthineers
  • Danaher

CT-NG Testing Market by Segment

The study includes a forecast for the global CT-NG testing market by type, application, and region.

CT-NG Testing Market by Type [Value from 2019 to 2031]:

  • Lab Tests
  • PoC Tests
  • Others

CT-NG Testing Market by Application [Value from 2019 to 2031]:

  • Diagnostic Laboratories
  • Hospitals & Clinics
  • Others

CT-NG Testing Market by Region [Value from 2019 to 2031]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the CT-NG Testing Market

The CT-NG (Chlamydia trachomatis and Neisseria gonorrhoeae) testing market has seen significant advancements, driven by technological innovations, increasing awareness of sexually transmitted infections (STIs), and growing demand for accessible, accurate diagnostics. In particular, rapid molecular diagnostic tests, such as nucleic acid amplification tests (NAATs), have led to improved accuracy and faster results. As healthcare systems in various countries, such as the United States, China, Germany, India, and Japan, continue to focus on STI control, the CT-NG testing market is evolving to meet these demands and align with changing healthcare priorities. Below are recent developments in key markets.

  • United States: In the U.S., CT-NG testing has become increasingly accessible due to the introduction of more user-friendly and rapid diagnostic tests. The U.S. Food and Drug Administration (FDA) has approved several new tests that offer higher sensitivity and specificity. There's a growing emphasis on point-of-care testing (POCT) and at-home testing kits, reflecting a shift toward convenient and cost-effective options. Furthermore, public health campaigns and government initiatives focused on increasing STI awareness and regular testing have contributed to the rise in demand for CT-NG testing, especially in sexually active populations and high-risk groups.
  • China: China has seen a rise in the adoption of CT-NG testing in both urban and rural areas, driven by increased public awareness of STIs and the need for more efficient diagnostic solutions. The government's healthcare reforms have led to the wider availability of testing in clinics and hospitals, particularly in regions with higher STI rates. Technological advancements in molecular diagnostics, such as NAAT, have further accelerated the market's growth. Additionally, China's large population and growing focus on public health have driven the development of more affordable and accessible CT-NG testing solutions.
  • Germany: Germany has implemented widespread CT-NG testing protocols as part of its national public health strategy. The country has focused on integrating rapid molecular diagnostic tests in routine sexual health screenings. Germany's healthcare system is well-equipped to offer comprehensive STI screening, and the use of NAATs has become a standard practice in most medical facilities. With a strong focus on STI prevention and treatment, the market is expanding, with more efficient, accurate, and faster diagnostic tools becoming available. Germany's proactive healthcare approach has contributed to increased adoption rates and more regular testing among the general population.
  • India: In India, the CT-NG testing market is growing, driven by rising awareness of STIs, particularly in urban areas. Government-backed initiatives to increase STI testing, along with the expansion of private healthcare facilities offering STI screenings, have fueled the market's growth. However, the availability and affordability of testing remain significant challenges in rural areas, where public health infrastructure is limited. In response, there have been advancements in mobile health clinics and affordable diagnostic solutions to expand access. Technological innovations, such as mobile-based testing solutions, are also gaining traction as potential game-changers in the market.
  • Japan: Japan has seen an increased focus on STI prevention and testing, with a significant rise in demand for CT-NG testing in clinics and hospitals. The integration of advanced diagnostic technologies, including PCR-based tests and NAATs, has enabled faster and more accurate results. Japan's well-developed healthcare system supports the widespread availability of testing, particularly in metropolitan areas. Additionally, there is a growing trend towards self-testing kits and increased awareness of sexual health, contributing to more widespread adoption of CT-NG testing across the population.

Features of the Global CT-NG Testing Market

  • Market Size Estimates: Ct-ng testing market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
  • Segmentation Analysis: Ct-ng testing market size by type, application, and region in terms of value ($B).
  • Regional Analysis: Ct-ng testing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different product, application, and regions for the CT-NG testing market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the CT-NG testing market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the CT-NG testing market by type (lab tests, PoC tests, and others), application (diagnostic laboratories, hospitals & clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

  • 2.1 Background and Classifications
  • 2.2 Supply Chain

3. Market Trends & Forecast Analysis

  • 3.1 Macroeconomic Trends and Forecasts
  • 3.2 Industry Drivers and Challenges
  • 3.3 PESTLE Analysis
  • 3.4 Patent Analysis
  • 3.5 Regulatory Environment

4. Global CT-NG Testing Market by Type

  • 4.1 Overview
  • 4.2 Attractiveness Analysis by Type
  • 4.3 Lab Tests: Trends and Forecast (2019-2031)
  • 4.4 PoC Tests: Trends and Forecast (2019-2031)
  • 4.5 Others: Trends and Forecast (2019-2031)

5. Global CT-NG Testing Market by Application

  • 5.1 Overview
  • 5.2 Attractiveness Analysis by Application
  • 5.3 Diagnostic Laboratories: Trends and Forecast (2019-2031)
  • 5.4 Hospitals & Clinics: Trends and Forecast (2019-2031)
  • 5.5 Others: Trends and Forecast (2019-2031)

6. Regional Analysis

  • 6.1 Overview
  • 6.2 Global CT-NG Testing Market by Region

7. North American CT-NG Testing Market

  • 7.1 Overview
  • 7.4 United States CT-NG Testing Market
  • 7.5 Mexican CT-NG Testing Market
  • 7.6 Canadian CT-NG Testing Market

8. European CT-NG Testing Market

  • 8.1 Overview
  • 8.4 German CT-NG Testing Market
  • 8.5 French CT-NG Testing Market
  • 8.6 Spanish CT-NG Testing Market
  • 8.7 Italian CT-NG Testing Market
  • 8.8 United Kingdom CT-NG Testing Market

9. APAC CT-NG Testing Market

  • 9.1 Overview
  • 9.4 Japanese CT-NG Testing Market
  • 9.5 Indian CT-NG Testing Market
  • 9.6 Chinese CT-NG Testing Market
  • 9.7 South Korean CT-NG Testing Market
  • 9.8 Indonesian CT-NG Testing Market

10. ROW CT-NG Testing Market

  • 10.1 Overview
  • 10.4 Middle Eastern CT-NG Testing Market
  • 10.5 South American CT-NG Testing Market
  • 10.6 African CT-NG Testing Market

11. Competitor Analysis

  • 11.1 Product Portfolio Analysis
  • 11.2 Operational Integration
  • 11.3 Porter's Five Forces Analysis
    • Competitive Rivalry
    • Bargaining Power of Buyers
    • Bargaining Power of Suppliers
    • Threat of Substitutes
    • Threat of New Entrants
  • 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

  • 12.1 Value Chain Analysis
  • 12.2 Growth Opportunity Analysis
    • 12.2.1 Growth Opportunities by Type
    • 12.2.2 Growth Opportunities by Application
  • 12.3 Emerging Trends in the Global CT-NG Testing Market
  • 12.4 Strategic Analysis
    • 12.4.1 New Product Development
    • 12.4.2 Certification and Licensing
    • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

  • 13.1 Competitive Analysis
  • 13.2 Roche
    • Company Overview
    • CT-NG Testing Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.3 Hologic
    • Company Overview
    • CT-NG Testing Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.4 Thermo Fisher Scientific
    • Company Overview
    • CT-NG Testing Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.5 Abbott Laboratories
    • Company Overview
    • CT-NG Testing Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.6 Bio-Rad Laboratories
    • Company Overview
    • CT-NG Testing Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.7 Siemens Healthineers
    • Company Overview
    • CT-NG Testing Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.8 Danaher
    • Company Overview
    • CT-NG Testing Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing

14. Appendix

  • 14.1 List of Figures
  • 14.2 List of Tables
  • 14.3 Research Methodology
  • 14.4 Disclaimer
  • 14.5 Copyright
  • 14.6 Abbreviations and Technical Units
  • 14.7 About Us
  • 14.8 Contact Us

List of Figures

  • Figure 1.1: Trends and Forecast for the Global CT-NG Testing Market
  • Figure 2.1: Usage of CT-NG Testing Market
  • Figure 2.2: Classification of the Global CT-NG Testing Market
  • Figure 2.3: Supply Chain of the Global CT-NG Testing Market
  • Figure 3.1: Trends of the Global GDP Growth Rate
  • Figure 3.2: Trends of the Global Population Growth Rate
  • Figure 3.3: Trends of the Global Inflation Rate
  • Figure 3.4: Trends of the Global Unemployment Rate
  • Figure 3.5: Trends of the Regional GDP Growth Rate
  • Figure 3.6: Trends of the Regional Population Growth Rate
  • Figure 3.7: Trends of the Regional Inflation Rate
  • Figure 3.8: Trends of the Regional Unemployment Rate
  • Figure 3.9: Trends of Regional Per Capita Income
  • Figure 3.10: Forecast for the Global GDP Growth Rate
  • Figure 3.11: Forecast for the Global Population Growth Rate
  • Figure 3.12: Forecast for the Global Inflation Rate
  • Figure 3.13: Forecast for the Global Unemployment Rate
  • Figure 3.14: Forecast for the Regional GDP Growth Rate
  • Figure 3.15: Forecast for the Regional Population Growth Rate
  • Figure 3.16: Forecast for the Regional Inflation Rate
  • Figure 3.17: Forecast for the Regional Unemployment Rate
  • Figure 3.18: Forecast for Regional Per Capita Income
  • Figure 3.19: Driver and Challenges of the CT-NG Testing Market
  • Figure 4.1: Global CT-NG Testing Market by Type in 2019, 2024, and 2031
  • Figure 4.2: Trends of the Global CT-NG Testing Market ($B) by Type
  • Figure 4.3: Forecast for the Global CT-NG Testing Market ($B) by Type
  • Figure 4.4: Trends and Forecast for Lab Tests in the Global CT-NG Testing Market (2019-2031)
  • Figure 4.5: Trends and Forecast for PoC Tests in the Global CT-NG Testing Market (2019-2031)
  • Figure 4.6: Trends and Forecast for Others in the Global CT-NG Testing Market (2019-2031)
  • Figure 5.1: Global CT-NG Testing Market by Application in 2019, 2024, and 2031
  • Figure 5.2: Trends of the Global CT-NG Testing Market ($B) by Application
  • Figure 5.3: Forecast for the Global CT-NG Testing Market ($B) by Application
  • Figure 5.4: Trends and Forecast for Diagnostic Laboratories in the Global CT-NG Testing Market (2019-2031)
  • Figure 5.5: Trends and Forecast for Hospitals & Clinics in the Global CT-NG Testing Market (2019-2031)
  • Figure 5.6: Trends and Forecast for Others in the Global CT-NG Testing Market (2019-2031)
  • Figure 6.1: Trends of the Global CT-NG Testing Market ($B) by Region (2019-2024)
  • Figure 6.2: Forecast for the Global CT-NG Testing Market ($B) by Region (2025-2031)
  • Figure 7.1: Trends and Forecast for the North American CT-NG Testing Market (2019-2031)
  • Figure 7.2: North American CT-NG Testing Market by Type in 2019, 2024, and 2031
  • Figure 7.3: Trends of the North American CT-NG Testing Market ($B) by Type (2019-2024)
  • Figure 7.4: Forecast for the North American CT-NG Testing Market ($B) by Type (2025-2031)
  • Figure 7.5: North American CT-NG Testing Market by Application in 2019, 2024, and 2031
  • Figure 7.6: Trends of the North American CT-NG Testing Market ($B) by Application (2019-2024)
  • Figure 7.7: Forecast for the North American CT-NG Testing Market ($B) by Application (2025-2031)
  • Figure 7.8: Trends and Forecast for the United States CT-NG Testing Market ($B) (2019-2031)
  • Figure 7.9: Trends and Forecast for the Mexican CT-NG Testing Market ($B) (2019-2031)
  • Figure 7.10: Trends and Forecast for the Canadian CT-NG Testing Market ($B) (2019-2031)
  • Figure 8.1: Trends and Forecast for the European CT-NG Testing Market (2019-2031)
  • Figure 8.2: European CT-NG Testing Market by Type in 2019, 2024, and 2031
  • Figure 8.3: Trends of the European CT-NG Testing Market ($B) by Type (2019-2024)
  • Figure 8.4: Forecast for the European CT-NG Testing Market ($B) by Type (2025-2031)
  • Figure 8.5: European CT-NG Testing Market by Application in 2019, 2024, and 2031
  • Figure 8.6: Trends of the European CT-NG Testing Market ($B) by Application (2019-2024)
  • Figure 8.7: Forecast for the European CT-NG Testing Market ($B) by Application (2025-2031)
  • Figure 8.8: Trends and Forecast for the German CT-NG Testing Market ($B) (2019-2031)
  • Figure 8.9: Trends and Forecast for the French CT-NG Testing Market ($B) (2019-2031)
  • Figure 8.10: Trends and Forecast for the Spanish CT-NG Testing Market ($B) (2019-2031)
  • Figure 8.11: Trends and Forecast for the Italian CT-NG Testing Market ($B) (2019-2031)
  • Figure 8.12: Trends and Forecast for the United Kingdom CT-NG Testing Market ($B) (2019-2031)
  • Figure 9.1: Trends and Forecast for the APAC CT-NG Testing Market (2019-2031)
  • Figure 9.2: APAC CT-NG Testing Market by Type in 2019, 2024, and 2031
  • Figure 9.3: Trends of the APAC CT-NG Testing Market ($B) by Type (2019-2024)
  • Figure 9.4: Forecast for the APAC CT-NG Testing Market ($B) by Type (2025-2031)
  • Figure 9.5: APAC CT-NG Testing Market by Application in 2019, 2024, and 2031
  • Figure 9.6: Trends of the APAC CT-NG Testing Market ($B) by Application (2019-2024)
  • Figure 9.7: Forecast for the APAC CT-NG Testing Market ($B) by Application (2025-2031)
  • Figure 9.8: Trends and Forecast for the Japanese CT-NG Testing Market ($B) (2019-2031)
  • Figure 9.9: Trends and Forecast for the Indian CT-NG Testing Market ($B) (2019-2031)
  • Figure 9.10: Trends and Forecast for the Chinese CT-NG Testing Market ($B) (2019-2031)
  • Figure 9.11: Trends and Forecast for the South Korean CT-NG Testing Market ($B) (2019-2031)
  • Figure 9.12: Trends and Forecast for the Indonesian CT-NG Testing Market ($B) (2019-2031)
  • Figure 10.1: Trends and Forecast for the ROW CT-NG Testing Market (2019-2031)
  • Figure 10.2: ROW CT-NG Testing Market by Type in 2019, 2024, and 2031
  • Figure 10.3: Trends of the ROW CT-NG Testing Market ($B) by Type (2019-2024)
  • Figure 10.4: Forecast for the ROW CT-NG Testing Market ($B) by Type (2025-2031)
  • Figure 10.5: ROW CT-NG Testing Market by Application in 2019, 2024, and 2031
  • Figure 10.6: Trends of the ROW CT-NG Testing Market ($B) by Application (2019-2024)
  • Figure 10.7: Forecast for the ROW CT-NG Testing Market ($B) by Application (2025-2031)
  • Figure 10.8: Trends and Forecast for the Middle Eastern CT-NG Testing Market ($B) (2019-2031)
  • Figure 10.9: Trends and Forecast for the South American CT-NG Testing Market ($B) (2019-2031)
  • Figure 10.10: Trends and Forecast for the African CT-NG Testing Market ($B) (2019-2031)
  • Figure 11.1: Porter's Five Forces Analysis of the Global CT-NG Testing Market
  • Figure 11.2: Market Share (%) of Top Players in the Global CT-NG Testing Market (2024)
  • Figure 12.1: Growth Opportunities for the Global CT-NG Testing Market by Type
  • Figure 12.2: Growth Opportunities for the Global CT-NG Testing Market by Application
  • Figure 12.3: Growth Opportunities for the Global CT-NG Testing Market by Region
  • Figure 12.4: Emerging Trends in the Global CT-NG Testing Market

List of Tables

  • Table 1.1: Growth Rate (%, 2023-2024) and CAGR (%, 2025-2031) of the CT-NG Testing Market by Type and Application
  • Table 1.2: Attractiveness Analysis for the CT-NG Testing Market by Region
  • Table 1.3: Global CT-NG Testing Market Parameters and Attributes
  • Table 3.1: Trends of the Global CT-NG Testing Market (2019-2024)
  • Table 3.2: Forecast for the Global CT-NG Testing Market (2025-2031)
  • Table 4.1: Attractiveness Analysis for the Global CT-NG Testing Market by Type
  • Table 4.2: Market Size and CAGR of Various Type in the Global CT-NG Testing Market (2019-2024)
  • Table 4.3: Market Size and CAGR of Various Type in the Global CT-NG Testing Market (2025-2031)
  • Table 4.4: Trends of Lab Tests in the Global CT-NG Testing Market (2019-2024)
  • Table 4.5: Forecast for Lab Tests in the Global CT-NG Testing Market (2025-2031)
  • Table 4.6: Trends of PoC Tests in the Global CT-NG Testing Market (2019-2024)
  • Table 4.7: Forecast for PoC Tests in the Global CT-NG Testing Market (2025-2031)
  • Table 4.8: Trends of Others in the Global CT-NG Testing Market (2019-2024)
  • Table 4.9: Forecast for Others in the Global CT-NG Testing Market (2025-2031)
  • Table 5.1: Attractiveness Analysis for the Global CT-NG Testing Market by Application
  • Table 5.2: Market Size and CAGR of Various Application in the Global CT-NG Testing Market (2019-2024)
  • Table 5.3: Market Size and CAGR of Various Application in the Global CT-NG Testing Market (2025-2031)
  • Table 5.4: Trends of Diagnostic Laboratories in the Global CT-NG Testing Market (2019-2024)
  • Table 5.5: Forecast for Diagnostic Laboratories in the Global CT-NG Testing Market (2025-2031)
  • Table 5.6: Trends of Hospitals & Clinics in the Global CT-NG Testing Market (2019-2024)
  • Table 5.7: Forecast for Hospitals & Clinics in the Global CT-NG Testing Market (2025-2031)
  • Table 5.8: Trends of Others in the Global CT-NG Testing Market (2019-2024)
  • Table 5.9: Forecast for Others in the Global CT-NG Testing Market (2025-2031)
  • Table 6.1: Market Size and CAGR of Various Regions in the Global CT-NG Testing Market (2019-2024)
  • Table 6.2: Market Size and CAGR of Various Regions in the Global CT-NG Testing Market (2025-2031)
  • Table 7.1: Trends of the North American CT-NG Testing Market (2019-2024)
  • Table 7.2: Forecast for the North American CT-NG Testing Market (2025-2031)
  • Table 7.3: Market Size and CAGR of Various Type in the North American CT-NG Testing Market (2019-2024)
  • Table 7.4: Market Size and CAGR of Various Type in the North American CT-NG Testing Market (2025-2031)
  • Table 7.5: Market Size and CAGR of Various Application in the North American CT-NG Testing Market (2019-2024)
  • Table 7.6: Market Size and CAGR of Various Application in the North American CT-NG Testing Market (2025-2031)
  • Table 7.7: Trends and Forecast for the United States CT-NG Testing Market (2019-2031)
  • Table 7.8: Trends and Forecast for the Mexican CT-NG Testing Market (2019-2031)
  • Table 7.9: Trends and Forecast for the Canadian CT-NG Testing Market (2019-2031)
  • Table 8.1: Trends of the European CT-NG Testing Market (2019-2024)
  • Table 8.2: Forecast for the European CT-NG Testing Market (2025-2031)
  • Table 8.3: Market Size and CAGR of Various Type in the European CT-NG Testing Market (2019-2024)
  • Table 8.4: Market Size and CAGR of Various Type in the European CT-NG Testing Market (2025-2031)
  • Table 8.5: Market Size and CAGR of Various Application in the European CT-NG Testing Market (2019-2024)
  • Table 8.6: Market Size and CAGR of Various Application in the European CT-NG Testing Market (2025-2031)
  • Table 8.7: Trends and Forecast for the German CT-NG Testing Market (2019-2031)
  • Table 8.8: Trends and Forecast for the French CT-NG Testing Market (2019-2031)
  • Table 8.9: Trends and Forecast for the Spanish CT-NG Testing Market (2019-2031)
  • Table 8.10: Trends and Forecast for the Italian CT-NG Testing Market (2019-2031)
  • Table 8.11: Trends and Forecast for the United Kingdom CT-NG Testing Market (2019-2031)
  • Table 9.1: Trends of the APAC CT-NG Testing Market (2019-2024)
  • Table 9.2: Forecast for the APAC CT-NG Testing Market (2025-2031)
  • Table 9.3: Market Size and CAGR of Various Type in the APAC CT-NG Testing Market (2019-2024)
  • Table 9.4: Market Size and CAGR of Various Type in the APAC CT-NG Testing Market (2025-2031)
  • Table 9.5: Market Size and CAGR of Various Application in the APAC CT-NG Testing Market (2019-2024)
  • Table 9.6: Market Size and CAGR of Various Application in the APAC CT-NG Testing Market (2025-2031)
  • Table 9.7: Trends and Forecast for the Japanese CT-NG Testing Market (2019-2031)
  • Table 9.8: Trends and Forecast for the Indian CT-NG Testing Market (2019-2031)
  • Table 9.9: Trends and Forecast for the Chinese CT-NG Testing Market (2019-2031)
  • Table 9.10: Trends and Forecast for the South Korean CT-NG Testing Market (2019-2031)
  • Table 9.11: Trends and Forecast for the Indonesian CT-NG Testing Market (2019-2031)
  • Table 10.1: Trends of the ROW CT-NG Testing Market (2019-2024)
  • Table 10.2: Forecast for the ROW CT-NG Testing Market (2025-2031)
  • Table 10.3: Market Size and CAGR of Various Type in the ROW CT-NG Testing Market (2019-2024)
  • Table 10.4: Market Size and CAGR of Various Type in the ROW CT-NG Testing Market (2025-2031)
  • Table 10.5: Market Size and CAGR of Various Application in the ROW CT-NG Testing Market (2019-2024)
  • Table 10.6: Market Size and CAGR of Various Application in the ROW CT-NG Testing Market (2025-2031)
  • Table 10.7: Trends and Forecast for the Middle Eastern CT-NG Testing Market (2019-2031)
  • Table 10.8: Trends and Forecast for the South American CT-NG Testing Market (2019-2031)
  • Table 10.9: Trends and Forecast for the African CT-NG Testing Market (2019-2031)
  • Table 11.1: Product Mapping of CT-NG Testing Suppliers Based on Segments
  • Table 11.2: Operational Integration of CT-NG Testing Manufacturers
  • Table 11.3: Rankings of Suppliers Based on CT-NG Testing Revenue
  • Table 12.1: New Product Launches by Major CT-NG Testing Producers (2019-2024)
  • Table 12.2: Certification Acquired by Major Competitor in the Global CT-NG Testing Market